Shen L - Search Results

1

Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer.

Lu Z, Chen H, Li S, Gong J, Li J, Zou J, Wu L, Yu J, Han W, Sun H, Jiao X, Zhang X, Peng Z, Lu M, Wang Z, Zhang H, Shen L. Lu Z, et al. Among authors: shen l. J Immunother Cancer. 2020 Aug;8(2):e000374. doi: 10.1136/jitc-2019-000374. J Immunother Cancer. 2020. PMID: 32792358 Free PMC article.

2

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L. Gong JF, et al. Among authors: shen l. Ai Zheng. 2007 Aug;26(8):890-4. Ai Zheng. 2007. PMID: 17697554 Free article. Chinese.

3

[Application of sandostatin in malignant bowel obstruction].

Li J, Jing ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Sep;10(5):479-81. Zhonghua Wei Chang Wai Ke Za Zhi. 2007. PMID: 17851794 Chinese.

4

[Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].

Zhang XD, Shen L, Li J, Li Y, Li J, Zhang XT, Jin ML. Zhang XD, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):474-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974288 Clinical Trial. Chinese.

5

A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.

Zhang X, Shen L, Li J, Li Y, Li J, Jin M. Zhang X, et al. Among authors: shen l. Am J Clin Oncol. 2008 Feb;31(1):29-33. doi: 10.1097/COC.0b013e3181131ca9. Am J Clin Oncol. 2008. PMID: 18376224 Clinical Trial.

6

[Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients].

Wang Y, Xu JM, Shen L, Xu N, Wang JW, Jiao SC, Zhang JS, Song ST, Li J, Bao HY, Yang L, Li F. Wang Y, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):913-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478930 Chinese.

7

[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].

Li J, Xu JM, Li J, Zhang XD, Bai Y, Chu YP, Wang YH, Liu DQ, Jin ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):225-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756942 Clinical Trial. Chinese.

8

[Cetuximab in combination with chemotherapy for patients with gastrointestinal cancer].

Zhang XT, Shen L, Zhang XD, Li J, Zhang ZT. Zhang XT, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):385-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18953842 Chinese.

9

[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].

Zhang J, Xiao Y, Lu M, Li J, Zhang XD, Li Y, Shen L. Zhang J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):312-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615292 Chinese.

10

[Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].

Lu M, Shen L, Li J, Li Y, Zhang XD. Lu M, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):392-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19799092 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,449 results

Search Page

Filters